| RS2521931086 |
TCEAL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with gait disturbance, dysmorphic facies |
| RS2521932028 |
DOCK11
|
Health Risk |
Pathogenic |
Inborn error of hematopoiesis and immunity with systemic inflammation and normocytic anemia, Inborn error of hematopoiesis and immunity with systemic inflammation and normocytic anemia |
| RS2521932919 |
AHDC1
|
Health Risk |
Likely pathogenic |
— |
| RS2521936399 |
ARID1A
|
Health Risk |
Likely pathogenic |
— |
| RS2521936815 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2521941756 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521943150 |
OCRL
|
Health Risk |
Likely pathogenic |
Dent disease type 2, Dent disease type 2 |
| RS2521943497 |
SBF1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4B3, Charcot-Marie-Tooth disease type 4B3 |
| RS2521944324 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related disorder, AHDC1-related disorder |
| RS2521945685 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS2521945695 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS2521947002 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2521947117 |
CSF2RA
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2521949809 |
WNK3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Prieto syndrome |
| RS2521949990 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS2521950956 |
WNK3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Nonpapillary renal cell carcinoma |
| RS2521951908 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2521952299 |
MT-TL1
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Primary mitochondrial disorders |
| RS2521954332 |
MT-TM
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Primary mitochondrial disorders |
| RS2521954674 |
STIL
|
Health Risk |
Likely pathogenic |
Microcephaly 7, primary |
| RS2521956863 |
MT-TN
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS2521957506 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2521958055 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2521958710 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521959483 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521959731 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521960362 |
B3GALT6
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia with joint laxity, Ehlers-Danlos syndrome |
| RS2521960553 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521961310 |
MT-CO2
|
Health Risk |
Likely pathogenic |
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency, Mitochondrial myopathy with reversible cytochrome C oxidase deficiency |
| RS2521961657 |
MT-TK
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Primary mitochondrial disorders |
| RS2521963003 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS2521963688 |
STAG2
|
Health Risk |
Pathogenic |
— |
| RS2521964059 |
MT-ATP6
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Leigh syndrome |
| RS2521972014 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2521973024 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521974385 |
VPS13D
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2521976752 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521979430 |
PTCH2
|
Health Risk |
Pathogenic |
Gorlin syndrome, Basal cell carcinoma |
| RS2521980025 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS2521980845 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS2521981696 |
ARID1A
|
Health Risk |
Pathogenic |
ARID1A-related disorder, ARID1A-related disorder |
| RS2521983222 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2521993448 |
MAGT1
|
Health Risk |
Likely pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2521993517 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2521993564 |
MAGT1
|
Health Risk |
Likely pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2521995500 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2521996795 |
MAGT1
|
Health Risk |
Likely pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2521999900 |
ARID1A
|
Health Risk |
Pathogenic |
— |
| RS2522000606 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2522000853 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2522001321 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2522002760 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS2522009301 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS2522010204 |
SBF1
|
Health Risk |
Likely pathogenic |
SBF1-related disorder, SBF1-related disorder |
| RS2522024333 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522024746 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522029781 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS2522032710 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522034049 |
ARID1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2522037796 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522038270 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522039523 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522039598 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522040167 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522040297 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2522041276 |
ARID1A
|
Health Risk |
Pathogenic |
ARID1A-related disorder, ARID1A-related disorder |
| RS2522041945 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522042642 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522043195 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2522043714 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522044176 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522044337 |
MECP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522045043 |
MECP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522045317 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522045420 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522045814 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2522046154 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522046319 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522047023 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522047206 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522047581 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522047825 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522048081 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522048158 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522048334 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522048372 |
MECP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522048399 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522048763 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522048965 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522048985 |
HUWE1
|
Health Risk |
Pathogenic |
Global developmental delay, Global developmental delay |
| RS2522049286 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522049393 |
MECP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522050035 |
ARID1A
|
Health Risk |
Pathogenic |
— |
| RS2522050550 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522051180 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522051281 |
MECP2
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2522051695 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522051892 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522051967 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522052671 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, MECP2-related disorder |